InvestorsHub Logo
Followers 23
Posts 1671
Boards Moderated 0
Alias Born 09/04/2009

Re: A1stockman post# 24456

Sunday, 02/26/2017 2:00:10 PM

Sunday, February 26, 2017 2:00:10 PM

Post# of 38634
Aegis reissued their buy rating on shares of Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSE:I) in a research report report published on Sunday morning. They currently have a $8.00 price target on the stock.